Viewing Study NCT00002451

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2026-02-03 @ 3:53 AM
Study NCT ID: NCT00002451
Status: UNKNOWN
Last Update Posted: 2005-06-24
First Post: 2000-01-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
Sponsor: Merck Sharp & Dohme LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Drug Therapy, Combination View
None Stavudine View
None HIV Protease Inhibitors View
None CD4 Lymphocyte Count View
None Ritonavir View
None Lamivudine View
None Indinavir View
None Reverse Transcriptase Inhibitors View
None Anti-HIV Agents View
None Viral Load View